94.65
-1.23
(-1.28%)
At close: January 13 at 4:00:02 PM EST
94.50
-0.15
(-0.16%)
Pre-Market: 6:03:34 AM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 39,199 | 4 |
| Sales | 57,105 | 9 |
| Net Shares Purchased (Sold) | -17,906 | 13 |
| Total Insider Shares Held | 1.74M | -- |
| % Net Shares Purchased (Sold) | -1.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MARKISON BRIAN A Chief Executive Officer | Conversion of Exercise of derivative security at price 6.00 - 12.42 per share. | Direct | 299,983 | Dec 19, 2024 |
| MARSHALL ROBERT J. JR. Chief Financial Officer | Sale at price 81.20 per share. | Direct | 812,000 | Nov 15, 2024 |
| BLANCHFIELD PAUL President | Stock Gift at price 0.00 per share. | Direct | 0 | Nov 14, 2024 |
| BLANCHFIELD PAUL President | Sale at price 79.65 per share. | Direct | 159,300 | Nov 14, 2024 |
| HEINO MARY ANNE Director | Sale at price 86.32 - 89.58 per share. | Direct | 1,001,218 | Nov 8, 2024 |
| EASTLAND JULIA MARIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 10, 2024 |
| THRALL JAMES H Director | Sale at price 98.52 per share. | Direct | 98,520 | Aug 21, 2024 |
| BROWN KIMBERLY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 15, 2024 |
| NIEDZWIECKI DANIEL M. General Counsel | Sale at price 97.54 per share. | Direct | 243,850 | Aug 14, 2024 |
| BER GERARD Director | Sale at price 96.23 - 97.78 per share. | Direct | 1,495,396 | Aug 12, 2024 |
| BLANCHFIELD PAUL President | Sale at price 96.39 per share. | Direct | 192,780 | Aug 8, 2024 |
| HEINO MARY ANNE Director | Sale at price 95.20 - 96.68 per share. | Direct | 1,000,900 | Aug 2, 2024 |
| SABENS ANDREA L Officer | Sale at price 123.15 - 124.96 per share. | Direct | 266,417 | Jul 16, 2024 |
| PRUDEN GARY J Director | Sale at price 95.04 per share. | Indirect | 1,190,851 | Jul 10, 2024 |
| HUMPHREY JEFFREY Officer | Stock Award(Grant) at price 82.63 per share. | Direct | 749,950 | Jun 17, 2024 |
| SABENS ANDREA L Officer | Sale at price 79.77 per share. | Direct | 27,202 | Jun 13, 2024 |
| BLANCHFIELD PAUL President | Sale at price 80.82 per share. | Direct | 95,287 | May 31, 2024 |
| NIEDZWIECKI DANIEL M. General Counsel | Sale at price 79.86 per share. | Direct | 1,028,038 | May 30, 2024 |
| MCHUGH JULIE H Director | Sale at price 78.50 per share. | Direct | 196,250 | May 28, 2024 |
| MAEUSLI HEINZ CHRISTOPH Director | Sale at price 77.71 - 80.29 per share. | Direct | 1,454,989 | May 28, 2024 |
| MAEUSLI HEINZ CHRISTOPH Director | Conversion of Exercise of derivative security at price 16.17 per share. | Direct | 282,668 | May 28, 2024 |
| PRUDEN GARY J Director | Stock Gift at price 0.00 per share. | Indirect | 0 | May 20, 2024 |
| SABENS ANDREA L Officer | Sale at price 76.89 per share. | Direct | 26,219 | May 13, 2024 |
| LENO SAMUEL R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| THRALL JAMES H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| MCHUGH JULIE H Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| HEINO MARY ANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| PRUDEN GARY J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| BER GERARD Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| BAYLOR-HENRY MINNIE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| MAEUSLI HEINZ CHRISTOPH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 9, 2024 |
| SABENS ANDREA L Officer | Sale at price 61.24 per share. | Direct | 20,883 | Apr 15, 2024 |
| MARSHALL ROBERT J. JR. Chief Financial Officer | Sale at price 60.00 per share. | Direct | 1,200,000 | Mar 15, 2024 |
| SABENS ANDREA L Officer | Sale at price 60.48 per share. | Direct | 20,624 | Mar 13, 2024 |
| BLANCHFIELD PAUL President | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BLANCHFIELD PAUL President | Sale at price 61.96 per share. | Direct | 1,116,705 | Mar 7, 2024 |
| LENO SAMUEL R Director | Sale at price 62.12 - 65.44 per share. | Direct | 262,005 | Mar 6, 2024 |
| LENO SAMUEL R Director | Conversion of Exercise of derivative security at price 16.30 per share. | Direct | 66,667 | Mar 6, 2024 |
| LENO SAMUEL R Director | Sale at price 64.81 - 65.60 per share. | Direct | 1,464,749 | Mar 4, 2024 |
| LENO SAMUEL R Director | Conversion of Exercise of derivative security at price 6.00 - 64.20 per share. | Direct | 444,499 | Mar 4, 2024 |
| HEINO MARY ANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| HEINO MARY ANNE Director | Sale at price 64.81 - 66.22 per share. | Direct | 6,129,889 | Mar 4, 2024 |
| MARSHALL ROBERT J. JR. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| BLANCHFIELD PAUL President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| NIEDZWIECKI DANIEL M. General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| MONTAGUT ETIENNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| SABENS ANDREA L Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2024 |
| MARKISON BRIAN A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| PROVOST JEAN-CLAUDE Officer | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Mar 1, 2024 |
| SABENS ANDREA L Officer | Sale at price 55.31 per share. | Direct | 18,861 | Feb 13, 2024 |
Related Tickers
NBIX Neurocrine Biosciences, Inc.
143.03
+1.51%
AMPH Amphastar Pharmaceuticals, Inc.
37.92
+4.29%
COLL Collegium Pharmaceutical, Inc.
33.79
+2.67%
HROW Harrow, Inc.
34.74
-5.26%
SIGA SIGA Technologies, Inc.
6.06
-2.42%
ITCI Intra-Cellular Therapies, Inc.
127.19
+34.07%
PCRX Pacira BioSciences, Inc.
21.13
+2.37%
ZTS Zoetis Inc.
166.32
+1.84%
AVDL Avadel Pharmaceuticals plc
7.82
-1.01%
ETON Eton Pharmaceuticals, Inc.
14.00
+4.17%